Type IV Hypersensitivity: The Only One With No Antibodies, and Why That Makes It Slow

A nurse gets her tuberculin skin test on Monday. Nothing happens that day. Nothing on Tuesday. She almost forgets about it. Then on Wednesday, two to three days later, a firm red lump rises at the injection site. Nothing was injected that could cause a lump on its own, just a tiny amount of harmless tuberculosis protein. The swelling is not the protein. It is her own T cells and macrophages, arriving slowly, recognizing an antigen they met years ago, and building an inflammatory reaction from scratch. That delay, the reason the test is read at 48 to 72 hours and not in minutes, is the signature of Type IV hypersensitivity. It is slow because, unlike every other hypersensitivity type, it uses no antibodies at all.

Hypersensitivity is a body’s response to a particular substance in an exaggerated way, which does not happen in normal cases. Hypersensitivity type IV is different from the rest of the other types of hypersensitivity as it is cell-mediated and delayed-type hypersensitivity. Unlike other types, it involves the interaction of T cells; therefore, it is not antibody-mediated. Since this process takes more time than reactions involving antibodies, a type IV reaction can be referred to as a delayed-type hypersensitivity reaction (DTH).

In DTH, the overreaction of the helper T cells (TH) and overproduction of cytokines damage tissues and cause inflammation and cell death. DTH responses can manifest from contact with allergens or infectious agents, where T lymphocytes have had prior encounters with antigen, giving rise to localized inflammation, erythema, and edema. Although DTH is detrimental, in some cases, the response plays an essential role in defense against intracellular pathogens and contact antigens.

The one idea that explains everything below

Type IV is the odd one out of the four hypersensitivity types, and one fact explains everything about it: it uses no antibodies.

Types I, II, and III are all antibody reactions. IgE in Type I, IgG or IgM in Types II and III. Antibodies are pre-made and fast, which is why those reactions happen in minutes to hours. Type IV throws antibodies out entirely. The work is done by T cells and the macrophages they command.

That single difference explains the two things students most need to know. First, why it is delayed. There is no pre-made antibody waiting to fire. Instead, memory T cells must find the antigen, release cytokines, and call in macrophages, and recruiting and activating those cells takes time. That is why a tuberculin test is read at 48 to 72 hours, not at 15 minutes like a Type I skin test.

Second, why its diseases look the way they do. When T cells and macrophages drive inflammation over days and the antigen is not cleared, the result is the classic Type IV picture: contact dermatitis on the skin, a firm tuberculin lump, and when it becomes chronic, a granuloma. These are not antibody diseases. They are T cell and macrophage diseases.

So every time you read a section below, anchor it to that one fact. No antibodies. T cells and macrophages. Slow by design.

History

Robert Koch first observed DTH. He observed such reactions in individuals infected with Mycobacterium tuberculosis. The patients developed a localized inflammatory response when injected intradermally with a filtrate derived from a mycobacterial culture. And he called this localized skin reaction a “tuberculin reaction.” Later on, other antigens were also found to induce such responses.

Mechanism

DTH reaction occurs in the initial sensitization phase and the effector phase.

Initial phase/ Sensitization phase

Figure: Type IV Hypersensitivity (Sensitization Phase)

The reaction begins when a foreign antigen is engulfed by antigen-presenting cells (APC). The antigen is expressed in a complex with the MHC-II on the surface of APC. It is recognized by the T helper cell.

Here, APC may be Langerhans (dendritic cells found in the epidermis) and macrophages or vascular endothelial cells. They pick antigens from the skin to regional lymph nodes, where the antigen activates T cells.

The activated helper T cell secretes autocrine cytokines, chiefly IL-2, which act back on the T cell itself to drive it to multiply. This clonal expansion produces a population of antigen-specific T cells, mostly of the TH1 type, along with memory T cells that persist for years.

T helper cells are the primary cells activated during the DTH response’s sensitizing phase (mostly TH1 and TH17). However, in some cases, Cytotoxic T cells are also found to induce a DTH response.

The antigens involved may be either intracellular pathogens or contact antigens. These are actually peptides derived from intracellular bacteria or contact antigens. Some of them are listed in the following table:

Table: Intracellular pathogens and contact antigens inducing DTH. Source: Kuby Immunology

The duration of the initial sensitization phase is 1 to 2 weeks after primary contact with an antigen.

Effector phase

Figure: Type IV Hypersensitivity (Effector Phase)

Macrophages are the principal effector cells of the DTH response. After a second or subsequent exposure of sensitized TH1 cells to antigen, TH1 cells secrete various cytokines and chemokines. These factors attract and activate macrophages and other non-specific inflammatory cells. Activated macrophages are more effective in presenting antigens.

The reaction does not appear before about 24 hours after re-exposure to the antigen, and it usually peaks at 48 to 72 hours. The delay exists because the cytokines released by T cells need time to draw macrophages into the site and activate them. There is no pre-made antibody to act instantly, so the reaction has to be built cell by cell. This is exactly why it is called delayed-type hypersensitivity.

Generally, this process kills pathogens rapidly with little tissue damage. However, in some cases, significantly, if the antigen is not quickly cleared, a prolonged DTH response can become destructive to the host. It may lead to a visible granulomatous reaction due to intensive and chronic inflammation.

Interferon-gamma from TH1 cells is the key macrophage-activating cytokine. It turns resting macrophages into activated macrophages that are far better at killing ingested pathogens. There are two arms of damage in the effector phase. Activated macrophages release hydrolytic enzymes and, in chronic reactions, fuse into multinucleated giant cells that wall off the antigen as a granuloma. Separately, cytotoxic CD8 T cells can kill infected target cells directly on contact. Which arm dominates depends on the antigen, and modern classifications split Type IV into subtypes on exactly this basis (see the note below).

The T cells involved in type IV reactions are memory cells derived from prior stimulation by the same antigen. These cells persist for months or years. When T cells are restimulated by the antigen presented on the surface of the APC, the T cells secrete cytokines that recruit and activate lymphocytes and phagocytic cells, which carry out the cell-mediated immune response.

A note on subtypes (for exams)

Older teaching treats Type IV as one mechanism. Modern classifications divide it into four subtypes based on which T cell and effector cell dominate. You do not need the fine detail at this level, but recognizing the framework is useful:

The classic delayed-type reaction you are learning here, tuberculin and contact dermatitis, is mostly subtype IVa.

Clinical manifestation

A broad range of inflammatory pathologies takes place. Erythema and edema, granuloma formation, fibrosis, and tissue necrosis can occur as the effect of DTH.

DTH reactions are prominent in autoimmune diseases and have also been demonstrated to play a role in response to transplantation. Some of the adverse effects are listed below:

Tuberculin reaction
This is the original and defining example of Type IV hypersensitivity, first described by Robert Koch. A small amount of tuberculosis protein (tuberculin, or PPD) is injected into the skin of a person whose T cells have met the antigen before, whether through past infection, active disease, or BCG vaccination. Over the next 48 to 72 hours, sensitized T cells recruit macrophages to the site, producing a firm, raised area of induration. The reaction is a positive tuberculin test. It shows only that the immune system has encountered the antigen before, not that the person currently has active tuberculosis.

The full procedure, how it is placed, how the induration is measured, and how the cutoffs are interpreted, is covered in the article on the tuberculin (Mantoux) skin test.

Contact dermatitis
It occurs after sensitization to simple environmental chemicals such as nickel, formaldehyde, cosmetics, soaps, and the urushiol in poison ivy and poison oak. These small molecules are too small to trigger an immune response on their own. They enter the skin and act as haptens, binding to the body's own proteins to form a complex the T cells then recognize. On a later exposure, the sensitized person develops redness, itching, blistering, eczema, and sometimes skin breakdown, typically within 12 to 48 hours. The hapten idea is the key teaching point: the chemical alone is invisible to the immune system until it attaches to a protein.

Granuloma
A granuloma forms when the antigen cannot be cleared, so macrophages stay activated for a long time. Under continuous stimulation, macrophages fuse into multinucleated giant cells and wall off the antigen. This organized cluster of cells forms a palpable nodule. The high concentration of lytic enzymes inside it can destroy surrounding tissue and cause necrosis. The classic example is the granuloma of tuberculosis, where the body cannot fully clear Mycobacterium tuberculosis and instead contains it. Other granulomatous lung conditions include hypersensitivity pneumonitis and granulomatosis with polyangiitis (formerly Wegener granulomatosis).

Transplant rejection
The host immune system can reject an organ or tissue graft from a genetically different donor. In acute cellular rejection, the recipient's T cells recognize the donor tissue as foreign and mount a cell-mediated attack, the same T cell and macrophage mechanism seen throughout Type IV.

Type 1 diabetes mellitus
Type 1 diabetes mellitus involves a cell-mediated attack on the pancreas. T cells and macrophages infiltrate the islets of Langerhans, and this cell-mediated destruction of the insulin-producing beta cells leads to insulin deficiency. It is a useful reminder that Type IV mechanisms underlie several organ-specific autoimmune diseases, not just skin and infection reactions.

Others
Multiple sclerosis is an autoimmune disease of the central nervous system in which T cells react against a self-antigen in the myelin sheath. Other Type IV-associated conditions include Hashimoto thyroiditis (inflammation of the thyroid gland) and the tissue damage seen in leprosy.

Diagnosis

Type IV reactions are diagnosed by delayed-read skin tests, which reproduce the reaction under controlled conditions. The two classic examples are the tuberculin (Mantoux) test, read at 48 to 72 hours for evidence of prior tuberculosis exposure, and the patch test for contact dermatitis, in which suspected allergens are applied to the skin and read after 48 to 96 hours. The delayed reading is the whole point: an immediate reaction would suggest Type I, not Type IV. Beyond skin testing, investigation depends on the specific disease, and may include routine blood, liver, thyroid, or kidney tests as the clinical picture requires.

Control

Many Type IV reactions, such as contact dermatitis, are uncomfortable rather than dangerous, and treatment focuses on removing the trigger and calming the inflammation. But this is not universally true. Some Type IV drug reactions, such as Stevens-Johnson syndrome and toxic epidermal necrolysis, are medical emergencies. So the severity depends entirely on the disease.

• Allergen avoidance can be a preventive measure in contact dermatitis.
• Steroids like prednisolone and dexamethasone can make the condition better.
• Type IV hypersensitivity can usually be resolved with topical corticosteroids.
• In severe or systemic disease, stronger immunosuppressive drugs such as cyclosporine or cyclophosphamide may be used under specialist supervision, because they suppress the T cell response that drives the reaction. The logic follows the mechanism: since Type IV is T cell-driven, the strongest treatments target T cells.

How to remember Type IV

No antibodies. That is the whole identity. Types I, II, and III all use antibodies. Type IV does not. It is T cells and macrophages only. If you remember one thing, remember that Type IV is the antibody-free, cell-mediated type. Everything else follows.

Delayed because it is built, not fired. The other types have pre-made antibodies ready to act in minutes. Type IV has to recruit and activate cells from scratch, which takes days. That is why the tuberculin test is read at 48 to 72 hours, not 15 minutes.

Four T's for Type IV. Type IV is Tuberculin, T cells, Transplant rejection, and Two to three days. Four T's for type four.

Read it late or you will call it wrong. The single most testable clinical point. A skin test read at 15 minutes tests Type I. A skin test read at 48 to 72 hours tests Type IV. The reading time tells you the type.

Hapten makes the invisible visible. In contact dermatitis, the chemical (nickel, urushiol) is too small for the immune system to see. It only becomes a target once it binds a body protein. The hapten binding is what turns a harmless small molecule into an allergen.

Key exam facts in one table

Where students get confused

"Type IV uses antibodies like the others." No. Type IV is the one hypersensitivity type with no antibodies at all. It is driven entirely by T cells and the macrophages they activate. This is the single fact that defines it.

"Delayed means mild." No. Delayed refers only to timing, not severity. The reaction is slow because it has to recruit cells, but Type IV includes tuberculosis granulomas and life-threatening drug reactions like toxic epidermal necrolysis.

"A positive tuberculin test means active tuberculosis." It does not. A positive tuberculin reaction means the person's T cells have met tuberculosis antigen before, from infection, past disease, or BCG vaccination. It shows sensitization, not active disease.

"The chemical in contact dermatitis is the allergen by itself." Not on its own. Nickel or urushiol is too small for the immune system to recognize alone. It must first bind a body protein as a hapten. Only the hapten-protein complex is recognized by T cells.

"Type IV and Type I allergy are read the same way on a skin test." They are read at opposite times. A Type I reaction shows a wheal within 15 to 20 minutes. A Type IV reaction shows a firm red lump at 48 to 72 hours. Reading a Type IV test too early will miss it.

"Granuloma formation means the immune system failed." It is better understood as containment. When the antigen cannot be destroyed, the macrophages wall it off in a granuloma to limit its spread. It is damage control, not simple failure.

References

• Punt J, Stranford SA, Jones PP, Owen JA. Kuby Immunology. 8th ed. New York: W. H. Freeman; 2019.
• Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology. 10th ed. Philadelphia: Elsevier; 2022.
• Delves PJ, Martin SJ, Burton DR, Roitt IM. Roitt's Essential Immunology. 13th ed. Chichester: Wiley-Blackwell; 2017.
• Marwa K, Kondamudi NP. Type IV Hypersensitivity Reaction. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.